Asia Pacific digital advertising in pharma market revenue is estimated to reach US$ 22264.3 million by 2031, growing at a compound annual growth rate (CAGR) of 13.8% during the forecast period.
Digital advertising is a promotional activity that provides the target audience through digital platforms, including search engines, social media, websites, and others. Digital advertising in the pharmaceutical industry is one of the simplest ways to connect prospects and advertise pharmaceutical services and products because the healthcare sector is expanding online on a massive scale.
Market Driving Factors
The increasing adoption of smartphones in the region, followed by the surge in internet penetration, the increasing development in the pharmaceutical industry in the region, and the surge in consideration for the rising incidences of chronic diseases are some of the primary elements expected to propel the market growth.
The pharmaceutical advertising industry is rapidly becoming automated which has significantly aided businesses. This mode of advertisement is cost-effective and offers greater scale and improved efficiency. Additionally, the rising investment by pharmaceutical industries in the region, along with the increasing adoption of cutting-edge technologies, such as deep learning, artificial intelligence, big data, and machine learning among others, are some of the elements predicted to fuel the market.
Ad blockers are present and privacy laws are evolving hamper the market growth.
Country Analysis
Japan is predicted to dominate the market in terms of revenue. This is due to the increasing pharmaceutical industry, and the rising transition of companies towards digital mode of business. Furthermore, the increasing penetration of the internet and the growing adoption of digital platforms by the end-users in the country are some of the additional elements expected to propel the market expansion.
Prominent Companies
Segmentation Outline
Asia Pacific digital advertising in pharma market segmentation focuses on Ad Format, Product Type, Category, Platform, and Country.
By Ad Format
By Product Type
By Category
By Platform
By Country
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL ASIA PACIFIC DIGITAL ADVERTISING IN PHARMA MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: ASIA PACIFIC DIGITAL ADVERTISING IN PHARMA MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL ASIA PACIFIC DIGITAL ADVERTISING IN PHARMA MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL ASIA PACIFIC DIGITAL ADVERTISING IN PHARMA MARKET, BY AD FORMAT
5.1 OVERVIEW
5.2 SOCIAL MEDIA ADS
NATIVE ADS
SEARCH ENGINE ADS
DISPLAY ADS
VIDEO ADVERTISING
MOBILE ADVERTISING
BANNER ADS
OTHER ADS
6 GLOBAL ASIA PACIFIC DIGITAL ADVERTISING IN PHARMA MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 PATENT
6.3 GENERIC MEDICINE
7 GLOBAL ASIA PACIFIC DIGITAL ADVERTISING IN PHARMA MARKET, BY CATEGORY
7.1 OVERVIEW
7.2 PRESCRIPTION
7.3 OTC DRUGS
8 GLOBAL ASIA PACIFIC DIGITAL ADVERTISING IN PHARMA MARKET, BY PLATFORM
8.1 OVERVIEW
8.2 MOBILE
8.3 DESKTOP
8.4 OTHERS
9 GLOBAL ASIA PACIFIC DIGITAL ADVERTISING IN PHARMA MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 ASIA PACIFIC
9.2.1 ASIA PACIFIC MARKET SNAPSHOT
9.2.2 SINGAPORE
9.2.3 INDONESIA
9.2.4 THAILAND
9.2.5 MALAYSIA
9.2.6 VIETNAM
9.2.7 PHILIPPINES
9.2.8 HONG KONG
9.2.9 TAIWAN
9.2.10 JAPAN
9.2.11 SOUTH KOREA
9.2.12 REST OF SOUTHEAST ASIA
9.2.13 REST OF ASIA
10 GLOBAL ASIA PACIFIC DIGITAL ADVERTISING IN PHARMA MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
10.4 COMPETITIVE DASHBOARD
10.5 PRODUCT MAPPING
10.6 TOP PLAYER POSITIONING, 2022
10.7 COMPETITIVE HEATMAP
10.8 TOP WINNING STRATEGIES
11 COMPANY PROFILES
11.1 BBDO
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.2 AMICULUM LIMITED
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.3 WEBHOPERS INFOTECH PVT. LTD
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.4 THE OGILVY GROUP
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.5 WEBFX DIGITAL MARKETING
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.6 AMURA MARKETING TECHNOLOGIES
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.7 MEDIBRANDOX
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved